| Dr Paul Munoz, MD | |
|
201 E Grover St, Shelby, NC 28150-3917 | |
| (919) 477-5152 | |
| (919) 477-5474 |
| Full Name | Dr Paul Munoz |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 26 Years |
| Location | 201 E Grover St, Shelby, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124079827 | NPI | - | NPPES |
| 8913545 | Medicaid | NC | |
| 13545 | Other | NC | BSNC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 200400067 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atrium Health Cleveland | Shelby, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolinas Emergency Physicians Pa | 8628055159 | 19 |
News Archive
It won't tackle global carbon emissions yet, but a new technology from Australia's national science agency, CSIRO, has found a way to pull carbon dioxide (CO2) out of the atmosphere and put it into beer and other beverages.
The Registered Nurses' Association of Ontario is pleased to announce the recipients of this year's Awards for Excellence in Health-Care Reporting.
Bristol-Myers Squibb Company today reported results for the second quarter of 2010 which featured data on key marketed and investigational compounds in its oncology, diabetes and cardiovascular franchises, and growth in sales and EPS. The company also confirmed guidance for 2010 and minimum guidance for non-GAAP EPS in 2013.
The first patient has now been enrolled into the Phase 1 clinical trial sponsored by Viral Genetics' and supported by a donation from Scott and White Foundation. The trial will study Metabolic Disruption Technology (MDT) compounds in combination with an existing cancer therapy to treat drug-resistant ovarian cancer.
University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus - health care workers.
› Verified 2 days ago
| Entity Name | Carolinas Emergency Physicians Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285952671 PECOS PAC ID: 8628055159 Enrollment ID: O20100715000317 |
News Archive
It won't tackle global carbon emissions yet, but a new technology from Australia's national science agency, CSIRO, has found a way to pull carbon dioxide (CO2) out of the atmosphere and put it into beer and other beverages.
The Registered Nurses' Association of Ontario is pleased to announce the recipients of this year's Awards for Excellence in Health-Care Reporting.
Bristol-Myers Squibb Company today reported results for the second quarter of 2010 which featured data on key marketed and investigational compounds in its oncology, diabetes and cardiovascular franchises, and growth in sales and EPS. The company also confirmed guidance for 2010 and minimum guidance for non-GAAP EPS in 2013.
The first patient has now been enrolled into the Phase 1 clinical trial sponsored by Viral Genetics' and supported by a donation from Scott and White Foundation. The trial will study Metabolic Disruption Technology (MDT) compounds in combination with an existing cancer therapy to treat drug-resistant ovarian cancer.
University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus - health care workers.
› Verified 2 days ago
| Entity Name | Carolina Cdu Specialists Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144720525 PECOS PAC ID: 7416210976 Enrollment ID: O20180414000005 |
News Archive
It won't tackle global carbon emissions yet, but a new technology from Australia's national science agency, CSIRO, has found a way to pull carbon dioxide (CO2) out of the atmosphere and put it into beer and other beverages.
The Registered Nurses' Association of Ontario is pleased to announce the recipients of this year's Awards for Excellence in Health-Care Reporting.
Bristol-Myers Squibb Company today reported results for the second quarter of 2010 which featured data on key marketed and investigational compounds in its oncology, diabetes and cardiovascular franchises, and growth in sales and EPS. The company also confirmed guidance for 2010 and minimum guidance for non-GAAP EPS in 2013.
The first patient has now been enrolled into the Phase 1 clinical trial sponsored by Viral Genetics' and supported by a donation from Scott and White Foundation. The trial will study Metabolic Disruption Technology (MDT) compounds in combination with an existing cancer therapy to treat drug-resistant ovarian cancer.
University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus - health care workers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul Munoz, MD 2926 Laura Rd, Shelby, NC 28150 Ph: (704) 481-8747 | Dr Paul Munoz, MD 201 E Grover St, Shelby, NC 28150-3917 Ph: (919) 477-5152 |
News Archive
It won't tackle global carbon emissions yet, but a new technology from Australia's national science agency, CSIRO, has found a way to pull carbon dioxide (CO2) out of the atmosphere and put it into beer and other beverages.
The Registered Nurses' Association of Ontario is pleased to announce the recipients of this year's Awards for Excellence in Health-Care Reporting.
Bristol-Myers Squibb Company today reported results for the second quarter of 2010 which featured data on key marketed and investigational compounds in its oncology, diabetes and cardiovascular franchises, and growth in sales and EPS. The company also confirmed guidance for 2010 and minimum guidance for non-GAAP EPS in 2013.
The first patient has now been enrolled into the Phase 1 clinical trial sponsored by Viral Genetics' and supported by a donation from Scott and White Foundation. The trial will study Metabolic Disruption Technology (MDT) compounds in combination with an existing cancer therapy to treat drug-resistant ovarian cancer.
University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus - health care workers.
› Verified 2 days ago
Dr. Matthew Edwin Dean, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 980-487-3000 | |
Dr. Ryan Christopher Matley, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 980-487-3131 | |
Dr. Jonathan Leake, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 980-487-3131 | |
Dr. Bruce Flitt, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 704-810-0376 Fax: 704-810-0376 | |
Richard K Hughlett, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 704-487-3131 | |
Michael L Adix, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 419 Earl Road, Shelby, NC 28150 Phone: 704-481-0555 Fax: 704-481-9169 |